Literature DB >> 23200709

Phenotyping clinical disorders: lessons learned from pelvic organ prolapse.

Jennifer M Wu1, Renée M Ward, Kristina L Allen-Brady, Todd L Edwards, Peggy A Norton, Katherine E Hartmann, Elizabeth R Hauser, Digna R Velez Edwards.   

Abstract

Genetic epidemiology, the study of genetic contributions to risk for disease, is an innovative area in medicine. Although research in this arena has advanced in other disciplines, few genetic epidemiological studies have been conducted in obstetrics and gynecology. It is crucial that we study the genetic susceptibility for issues in women's health because this information will shape the new frontier of personalized medicine. To date, preterm birth may be one of the best examples of genetic susceptibility in obstetrics and gynecology, but many areas are being evaluated including endometriosis, fibroids, polycystic ovarian syndrome, and pelvic floor disorders. An essential component to genetic epidemiological studies is to characterize, or phenotype, the disorder to identify genetic effects. Given the growing importance of genomics and genetic epidemiology, we discuss the importance of accurate phenotyping of clinical disorders and highlight critical considerations and opportunities in phenotyping, using pelvic organ prolapse as a clinical example.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23200709      PMCID: PMC3597745          DOI: 10.1016/j.ajog.2012.11.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  55 in total

1.  Reproductive factors, family history, occupation and risk of urogenital prolapse.

Authors:  F Chiaffarino; L Chatenoud; M Dindelli; M Meschia; A Buonaguidi; F Amicarelli; M Surace; E Bertola; E Di Cintio; F Parazzini
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-01       Impact factor: 2.435

Review 2.  Population stratification and spurious allelic association.

Authors:  Lon R Cardon; Lyle J Palmer
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

3.  The effects of human population structure on large genetic association studies.

Authors:  Jonathan Marchini; Lon R Cardon; Michael S Phillips; Peter Donnelly
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

4.  Assessing the impact of population stratification on genetic association studies.

Authors:  Matthew L Freedman; David Reich; Kathryn L Penney; Gavin J McDonald; Andre A Mignault; Nick Patterson; Stacey B Gabriel; Eric J Topol; Jordan W Smoller; Carlos N Pato; Michele T Pato; Tracey L Petryshen; Laurence N Kolonel; Eric S Lander; Pamela Sklar; Brian Henderson; Joel N Hirschhorn; David Altshuler
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

Review 5.  Questionnaires for women with pelvic floor disorders.

Authors:  Matthew D Barber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-21

6.  Parity, mode of delivery, and pelvic floor disorders.

Authors:  Emily S Lukacz; Jean M Lawrence; Richard Contreras; Charles W Nager; Karl M Luber
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

7.  Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?

Authors:  Matthew D Barber; Nikki L Neubauer; Victoria Klein-Olarte
Journal:  Am J Obstet Gynecol       Date:  2006-05-08       Impact factor: 8.661

8.  Sequence variant in the laminin gamma1 (LAMC1) gene associated with familial pelvic organ prolapse.

Authors:  Ganka Nikolova; Hane Lee; Suzanne Berkovitz; Stanley Nelson; Janet Sinsheimer; Eric Vilain; Larissa V Rodríguez
Journal:  Hum Genet       Date:  2006-10-05       Impact factor: 4.132

9.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).

Authors:  M D Barber; M D Walters; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

10.  Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity.

Authors:  Susan L Hendrix; Amanda Clark; Ingrid Nygaard; Aaron Aragaki; Vanessa Barnabei; Anne McTiernan
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661

View more
  6 in total

Review 1.  Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium.

Authors:  Signe Altmäe; Francisco J Esteban; Anneli Stavreus-Evers; Carlos Simón; Linda Giudice; Bruce A Lessey; Jose A Horcajadas; Nick S Macklon; Thomas D'Hooghe; Cristina Campoy; Bart C Fauser; Lois A Salamonsen; Andres Salumets
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

2.  International Urogynecological Consultation: clinical definition of pelvic organ prolapse.

Authors:  Sarah A Collins; Michele O'Shea; Nicola Dykes; Olga Ramm; Autumn Edenfield; Ka Lai Shek; Kim van Delft; Molly Beestrum; Kimberly Kenton
Journal:  Int Urogynecol J       Date:  2021-06-30       Impact factor: 2.894

3.  Clinical characteristics of women with familial pelvic floor disorders.

Authors:  Peggy A Norton; K Allen-Brady; J Wu; M Egger; L Cannon-Albright
Journal:  Int Urogynecol J       Date:  2014-10-29       Impact factor: 2.894

Review 4.  Genetic epidemiology of pelvic organ prolapse: a systematic review.

Authors:  Renée M Ward; Digna R Velez Edwards; Todd Edwards; Ayush Giri; Rebecca N Jerome; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2014-04-12       Impact factor: 8.661

5.  Phenotyping chronic pelvic pain based on latent class modeling of physical examination.

Authors:  B W Fenton; S F Grey; M Reichenbach; M McCarroll; V Von Gruenigen
Journal:  Pain Res Treat       Date:  2013-12-22

6.  Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women's Health Initiative.

Authors:  Ayush Giri; Jennifer M Wu; Renee M Ward; Katherine E Hartmann; Amy J Park; Kari E North; Mariaelisa Graff; Robert B Wallace; Gihan Bareh; Lihong Qi; Mary J O'Sullivan; Alexander P Reiner; Todd L Edwards; Digna R Velez Edwards
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.